NeuronicLABs
NeuronicLABs is a Toronto-based medical device company focused on developing and commercializing advanced molecular diagnostic technologies. Their flagship product, the QT100Dx system, is a fully automated RNA detection platform designed for decentralized point-of-care use, capable of detecting multiple RNA and protein targets with high sensitivity and specificity. The system integrates nanotechnology, AI-driven analytics, robotics, and a HIPAA-compliant cloud platform for real-time tracking and analysis. Currently under development, the QT100Dx aims to democratize diagnostics by providing cost-effective, rapid, and user-friendly molecular testing solutions, particularly for RNA viruses in human saliva. The company collaborates with academic and industry partners to advance its technology and disrupt the diagnostics market.
NeuronicLABs
NeuronicLABs is a Toronto-based medical device company focused on developing and commercializing advanced molecular diagnostic technologies. Their flagship product, the QT100Dx system, is a fully automated RNA detection platform designed for decentralized point-of-care use, capable of detecting multiple RNA and protein targets with high sensitivity and specificity. The system integrates nanotechnology, AI-driven analytics, robotics, and a HIPAA-compliant cloud platform for real-time tracking and analysis. Currently under development, the QT100Dx aims to democratize diagnostics by providing cost-effective, rapid, and user-friendly molecular testing solutions, particularly for RNA viruses in human saliva. The company collaborates with academic and industry partners to advance its technology and disrupt the diagnostics market.